Managing the growing incidence of diabetes in England is set to be one of the major clinical challenges of the 21st century. Estimates suggest that the number of people with diabetes is expected to rise to 4.2 million people by 2030, affecting almost 9% of the population.
The NHS Diabetes Prevention Programme is delivering a systematic approach to reducing the risk of individuals developing diabetes. However, it is equally important that the outcomes for those with diabetes are improved and unjustified variation is reduced.
The importance of improving outcomes for individuals with diabetes is reflected in the inclusion in the CCG Improvement and Assessment Framework (CCG IAF) of indicators covering:
- Diabetes patients that have achieved all the NICE recommended treatment targets: Three (HbA1c (blood sugar), cholesterol and blood pressure) for adults and one (HbA1c) for children
- People with diabetes diagnosed less than a year who attend a structured education course
These have been selected because they are recognised evidence-based measures of whether patients with diabetes are being supported to successfully manage their condition.
As part of the CCG IAF, a support offer is being developed for each of the clinical priority areas within it. For diabetes, the support offer will form part of a wider treatment and care programme which will work in conjunction with regional commissioning operation teams, clinical networks and NHS RightCare to promote an integrated approach to supporting improvement in diabetes outcomes.